누트라폴 관련 여성형 탈모증
A 근거 여러 대규모 임상 시험이 일관되게 유의미한 효과를 보여줍니다.총 2,213명의 참여자를 대상으로 한 9건의 연구(메타분석 2건, RCT 2건)에 근거합니다. 9건 중 9건의 연구에서 긍정적인 효과가 나타났습니다.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'haircited.com';
const params = 'ingredient\u003Dnutrafol\u0026condition\u003Dfemale\u002Dpattern\u002Dhair\u002Dloss';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
A
결론
Nutrafol is well-supported by research as a nutraceutical that may help promote hair growth and improve hair quality in women experiencing pattern hair loss.
- 9 out of 9 studies show positive effects — 100% consistency
- Includes 2 placebo-controlled RCTs and 2 meta-analyses
- Demonstrated benefits across premenopausal, perimenopausal, and postmenopausal women
- Improvements seen in both hair growth and hair fiber quality
Key Study Findings
systematic review
n=1658
Double-blind
Effects of dietary supplements on androgenetic alopecia: a systematic review and network meta-analysis.
Dose: various dietary supplements (Nutrafol, apple extract, tocotrienols, pumpkin seed oil, Cistanche/Lami
vs: Placebo
효과: None
None
Cohort Study
n=11276
416 weeks
Dietary folate intake and its association with longitudinal changes in cognition function.
Dose: 50%
vs: None
Outcome: cognitive function
효과: None
P = 0.015
대상 집단: None
Observational Study
n=75
Dietary Intakes of Folate, Vitamin D and Iodine during the First Trimester of Pregnancy and …
Dose: 5 mg folic acid (higher dose for obesity)
vs: None
Outcome: Dietary and supplementary intake adequacy
효과: 96% took folic acid; 26% took 5mg dose
None
대상 집단: Pregnant women with obesity (BMI>=30) in UK
review
Nutraceuticals for Androgenetic Alopecia.
Dose: Nutrafol and Viviscal (oral nutraceuticals); doses per product labeling
vs: Placebo
효과: None
None
systematic_review_meta_analysis
24 weeks
Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and continuous Bayesian …
Dose: ALRV5XR, dutasteride 0.5 mg/day, finasteride 1 mg/day, LLLT, minoxidil 2%/5%, Nutrafol, Viviscal
vs: Placebo
효과: Women 24wk: ALRV5XR 30.09, LLLT 16.62, Minoxidil 2% 12.13 THs/cm2. Men: ALRV5XR 21.03, LLLT 18.75, D
statistically significant for
Review
A landscape of micronutrient status in women through the reproductive years: Insights from seven regions …
Dose: None
vs: None
Outcome: None
효과: None
None
대상 집단: None
Key Statistics
8
연구
13009
참여자
↔
Mixed
A
등급
Referenced Papers
Effects of dietary supplements on androgenetic alopecia: a systematic review and network meta-analysis.
Systematic Review
Frontiers in nutrition
2025
Clinical nutrition ESPEN
2023
5 인용
Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and continuous Bayesian network meta-analysis.
Systematic Review
Frontiers in medicine
2022
14 인용
The Journal of …
2022
9 인용
Nutrients
2022
6 인용
Women's health (London, …
2020
13 인용
Clinical nutrition (Edinburgh, …
2014
18 인용
International journal of …
2006
176 인용
Stroke
2002
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
일반적으로 사용되는 용량
- hairloss:
- 4 capsules/day
상한량: Not established
연구에서 사용된 용량
| 용량 | 기간 | 효과 | N |
|---|---|---|---|
| various dietary supplements (Nutrafol, apple extract, tocotrienols, pumpkin seed oil, Cistanche/Lami | -- | Positive | 1658 |
| 50% | 416 weeks | Mixed | 11276 |
| 5 mg folic acid (higher dose for obesity) | -- | Mixed | 75 |
| Nutrafol and Viviscal (oral nutraceuticals); doses per product labeling | -- | Positive | -- |
| ALRV5XR, dutasteride 0.5 mg/day, finasteride 1 mg/day, LLLT, minoxidil 2%/5%, Nutrafol, Viviscal | 24 weeks | Positive | -- |
| None | -- | Mixed | -- |
| 300-400 mcg DFE/day | -- | Positive | -- |
| None | -- | Mixed | -- |
권장 복용 시간: 4 capsules together with a meal
Safety & Side Effects
보고된 부작용
- ⚠ Mild gastrointestinal discomfort
- ⚠ Headache (possibly from ashwagandha)
- ⚠ Allergic reactions in individuals sensitive to any component
- ⚠ Potential thyroid stimulation from ashwagandha
알려진 상호작용
- ● Thyroid medications (ashwagandha may affect thyroid function)
- ● Anticoagulants (curcumin and saw palmetto may increase bleeding risk)
- ● Immunosuppressants (ashwagandha may stimulate immune activity)
- ● Sedatives and anxiolytics (ashwagandha has calming properties)
일일 최대 섭취 허용량: Not established
건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.
Frequently Asked Questions
Does 누트라폴 help with 여성형 탈모증?
Based on 8 studies with 13,009 participants, there is strong evidence from multiple clinical trials that 누트라폴 may support 여성형 탈모증 management. Our evidence grade is A (Strong Evidence).
How much 누트라폴 should I take for 여성형 탈모증?
Studies have used various dosages. A commonly studied range is 4 capsules/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of 누트라폴?
Reported side effects may include Mild gastrointestinal discomfort, Headache (possibly from ashwagandha), Allergic reactions in individuals sensitive to any component, Potential thyroid stimulation from ashwagandha. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for 누트라폴 and 여성형 탈모증?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 8 peer-reviewed studies with 13,009 total participants. The overall direction of effect is mixed.
Related Evidence
관련 다른 성분: 여성형 탈모증
누트라폴 다른 건강 상태에 대한 근거
References
- [1] Lei Zhou et al.. Front Nutr. 2025. Effects of dietary supplements on androgenetic alopecia: a systematic review and network meta-analysis. doi:10.3389/fnut.2025.1719711 PubMed
- [2] Cecília Zanin Palchetti et al.. Clin Nutr ESPEN. 2023. Dietary folate intake and its association with longitudinal changes in cognition function. doi:10.1016/j.clnesp.2023.04.013 PubMed
- [3] Peter R Feldman et al.. Front Med (Lausanne). 2022. Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and continuous Bayesian network meta-analysis. doi:10.3389/fmed.2022.998623 PubMed
- [4] Christina Ring et al.. J Clin Aesthet Dermatol. 2022. Nutraceuticals for Androgenetic Alopecia. PubMed
- [5] Kathy M Redfern et al.. Nutrients. 2022. Dietary Intakes of Folate, Vitamin D and Iodine during the First Trimester of Pregnancy and the Association between Supplement Use … doi:10.3390/nu14235135 PubMed
- [6] Mary Foong-Fong Chong et al.. Womens Health (Lond). 2020. A landscape of micronutrient status in women through the reproductive years: Insights from seven regions in Asia. doi:10.1177/1745506520973110 PubMed
- [7] Rima Obeid et al.. Clin Nutr. 2014. Critical evaluation of lowering the recommended dietary intake of folate. doi:10.1016/j.clnu.2013.12.013 PubMed
- [8] Kathleen Woolf et al.. Int J Sport Nutr Exerc Metab. 2006. B-vitamins and exercise: does exercise alter requirements? doi:10.1123/ijsnem.16.5.453 PubMed
- [9] Scott E Kasner. Stroke. 2002. Folate and the risk of stroke: fortify first and ask questions later? PubMed
FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.